226 related articles for article (PubMed ID: 16368504)
1. Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer.
House MG; Cameron JL; Lillemoe KD; Schulick RD; Choti MA; Hansel DE; Hruban RH; Maitra A; Yeo CJ
J Gastrointest Surg; 2006 Jan; 10(1):138-45. PubMed ID: 16368504
[TBL] [Abstract][Full Text] [Related]
2. Surgical treatment of non-functioning pancreatic neuroendocrine tumours based on three clinical scenarios.
Busquets J; Ramírez-Maldonado E; Serrano T; Peláez N; Secanella L; Ruiz-Osuna S; Ramos E; Lladó L; Fabregat J
Cir Esp; 2016 Dec; 94(10):578-587. PubMed ID: 27863693
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of malignant pancreatic islet cell tumors].
Egorov AV; Kuzin NM; Kondrashin SA; Lotov AN; Kazantseva IA; Kuznetsov NS; Gurevich LE; Lakreeva MG
Khirurgiia (Mosk); 2000; (5):13-7. PubMed ID: 10842959
[TBL] [Abstract][Full Text] [Related]
4. Assessing the role of primary tumour resection in patients with synchronous unresectable liver metastases from pancreatic neuroendocrine tumour of the body and tail. A propensity score survival evaluation.
Bertani E; Fazio N; Radice D; Zardini C; Spinoglio G; Chiappa A; Ribero D; Biffi R; Partelli S; Falconi M
Eur J Surg Oncol; 2017 Feb; 43(2):372-379. PubMed ID: 27742480
[TBL] [Abstract][Full Text] [Related]
5. Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas.
Bettini R; Mantovani W; Boninsegna L; Crippa S; Capelli P; Bassi C; Scarpa A; Pederzoli P; Falconi M
Dig Liver Dis; 2009 Jan; 41(1):49-55. PubMed ID: 18463008
[TBL] [Abstract][Full Text] [Related]
6. Effective TAE therapy using Lipiodol with epirubicin for liver metastases of nonfunctioning islet cell carcinoma of the pancreas.
Naka T; Ashida K; Takahashi S; Kaneko T; Mizusawa K; Kaibara N
J Hepatobiliary Pancreat Surg; 1998; 5(1):108-12. PubMed ID: 9683763
[TBL] [Abstract][Full Text] [Related]
7. Laparoscopic resection of a pancreatic polypeptidoma with a solitary liver metastasis.
Chan WF; Lo CY; Lo CM; Fan ST
Surg Endosc; 2004 Mar; 18(3):554-6. PubMed ID: 15115015
[TBL] [Abstract][Full Text] [Related]
8. Role of resection of the primary pancreatic neuroendocrine tumor in the multidisciplinary treatment of patients with unresectable synchronous liver metastases: a case series.
Kondo NI; Ikeda Y; Maehara S; Sugimoto R; Nishiyama K; Sakaguchi Y
JOP; 2013 Jul; 14(4):415-22. PubMed ID: 23846939
[TBL] [Abstract][Full Text] [Related]
9. Is surgery indicated for patients with symptomatic nonfunctioning pancreatic neuroendocrine tumor and unresectable hepatic metastases?
Hung JS; Chang MC; Lee PH; Tien YW
World J Surg; 2007 Dec; 31(12):2392-7. PubMed ID: 17960455
[TBL] [Abstract][Full Text] [Related]
10. Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?
Fernández-Cruz L; Blanco L; Cosa R; Rendón H
World J Surg; 2008 May; 32(5):904-17. PubMed ID: 18264824
[TBL] [Abstract][Full Text] [Related]
11. Natural history of a patient with malignant nonfunctioning islet cell tumor associated with unresectable multiple liver metastases.
Noda H; Toyama N; Suminaga Y; Konishi F
J Exp Clin Cancer Res; 2004 Jun; 23(2):349-51. PubMed ID: 15354423
[TBL] [Abstract][Full Text] [Related]
12. Strategy for pancreatic endocrine tumors.
Sato T; Konishi K; Kimura H; Maeda K; Yabushita K; Tsuji M; Demachi H; Miwa A
Hepatogastroenterology; 2000; 47(32):537-9. PubMed ID: 10791232
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic carcinoid: transcatheter arterial chemoembolization of liver metastases.
Gunji N; Miyamoto H; Orii K; Kawamoto T; Fukao K
Hepatogastroenterology; 2003; 50(54):2166-8. PubMed ID: 14696488
[TBL] [Abstract][Full Text] [Related]
14. Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis.
Tachezy M; Gebauer F; Janot M; Uhl W; Zerbi A; Montorsi M; Perinel J; Adham M; Dervenis C; Agalianos C; Malleo G; Maggino L; Stein A; Izbicki JR; Bockhorn M
Surgery; 2016 Jul; 160(1):136-144. PubMed ID: 27048934
[TBL] [Abstract][Full Text] [Related]
15. Concurrent resections of pancreatic islet cell cancers with synchronous hepatic metastases: outcomes of an aggressive approach.
Sarmiento JM; Que FG; Grant CS; Thompson GB; Farnell MB; Nagorney DM
Surgery; 2002 Dec; 132(6):976-82; discussion 982-3. PubMed ID: 12490844
[TBL] [Abstract][Full Text] [Related]
16. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
17. Resection of synchronous liver metastases from colorectal cancer.
Fujita S; Akasu T; Moriya Y
Jpn J Clin Oncol; 2000 Jan; 30(1):7-11. PubMed ID: 10770561
[TBL] [Abstract][Full Text] [Related]
18. The role of hepatectomy for synchronous liver metastases from pancreatic adenocarcinoma.
Andreou A; Knitter S; Klein F; Malinka T; Schmelzle M; Struecker B; Schmuck RB; Noltsch AR; Lee D; Pelzer U; Denecke T; Pratschke J; Bahra M
Surg Oncol; 2018 Dec; 27(4):688-694. PubMed ID: 30449494
[TBL] [Abstract][Full Text] [Related]
19. Solid pseudopapillary tumors of the pancreas. Clinical features, surgical outcomes, and long-term survival in 45 consecutive patients from a single center.
Butte JM; Brennan MF; Gönen M; Tang LH; D'Angelica MI; Fong Y; Dematteo RP; Jarnagin WR; Allen PJ
J Gastrointest Surg; 2011 Feb; 15(2):350-7. PubMed ID: 20824369
[TBL] [Abstract][Full Text] [Related]
20. Clinical Analysis of Acinar Cell Carcinoma of the Pancreas: A Single-Center Experience of 45 Consecutive Cases.
Zhou W; Han X; Fang Y; Han S; Cai Y; Kuang T; Lou W; Wang D
Cancer Control; 2020; 27(1):1073274820969447. PubMed ID: 33121259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
